Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-503 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-92 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
filingDate |
1998-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1999-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4aac4ca25d1b9c61ea02ccf65b5f52a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a12710665ce93bb7cf0ef4001c01f4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b0d913cdd6310b7edc2e776ca923e4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_561409d84dd58c3df1ec5969b9aa292b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95deec1b4a9651506435112bfd567f09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dd04d4cbb80bb582c4fcbe4a54a79a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_933f4974b649dfc9ea684252472cf4e6 |
publicationDate |
1999-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6008033-A |
titleOfInvention |
Proteases, compositions capable of binding to said site, and methods of use thereof |
abstract |
Novel herpes viral protease crystalline structures are identified which have an active site formed by the three amino acids Ser, His and His. Also disclosed are methods of identifying inhibitors of these proteases and/or active sites. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0214344-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004137518-A1 |
priorityDate |
1996-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |